Bill Snyder

Synthetic biology expert Collins set to speak at Vanderbilt

Boston University biomedical engineer and MacArthur Fellow James Collins, Ph.D., will lecture at 3:10 p.m. Oct. 23 in the Jacobs Believed in Me Auditorium, part of the Vanderbilt School of Engineering’s Featheringill Hall.

New target for stopping inflammation

Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases.

Clinical and translational research highlighted at retreat

Kathleen Neuzil, M.D., MPH, known internationally for her efforts to expand vaccine access and delivery around the world, credited her Vanderbilt University mentors last week for guiding her to a career path that allowed her to “make a difference.”

Discovery Lecturer makes case for stronger science

The occasional failings of science tend to draw big headlines — findings that can’t be replicated or increasing numbers of papers that are retracted because studies were improperly or even fraudulently conducted.

VUMC poised to overcome health care challenges: Balser

While the national economy appears to be getting stronger, health care has entered a national recession, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the Vanderbilt University School of Medicine, told a packed audience of approximately 1,100 Vanderbilt faculty, staff and students in Langford Auditorium on Wednesday afternoon while making his annual State of the Medical Center address.

VU’s technology commercialization efforts make strides

Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.

1 100 101 102 103 104 115